Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

Sunway Medical Centre, Sunway City consultant physician, respiratory medicine and interventional pulmonologist Dr Syed Ajmal Syed Ali said that low awareness is one of Malaysia's biggest challenges in ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets.

Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

France: In non-COPD patients at high risk of extubation failure, prophylactic noninvasive ventilation (NIV) alternating with ...

British drug maker GSK plc (GSK, GSK.L) announced Monday that the U.S. Food and Drug Administration has accepted for review, data ...